Literature DB >> 27317807

The methyltransferase Setdb1 is essential for meiosis and mitosis in mouse oocytes and early embryos.

Angeline Eymery1, Zichuan Liu1, Evgeniy A Ozonov1, Michael B Stadler2, Antoine H F M Peters3.   

Abstract

Oocytes develop the competence for meiosis and early embryogenesis during their growth. Setdb1 is a histone H3 lysine 9 (H3K9) methyltransferase required for post-implantation development and has been implicated in the transcriptional silencing of genes and endogenous retroviral elements (ERVs). To address its role in oogenesis and pre-implantation development, we conditionally deleted Setdb1 in growing oocytes. Loss of Setdb1 expression greatly impaired meiosis. It delayed meiotic resumption, altered the dynamics of chromatin condensation, and impaired kinetochore-spindle interactions, bipolar spindle organization and chromosome segregation in more mature oocytes. The observed phenotypes related to changes in abundance of specific transcripts in mutant oocytes. Setdb1 maternally deficient embryos arrested during pre-implantation development and showed comparable defects during cell cycle progression and in chromosome segregation. Finally, transcriptional profiling data indicate that Setdb1 downregulates rather than silences expression of ERVK and ERVL-MaLR retrotransposons and associated chimearic transcripts during oogenesis. Our results identify Setdb1 as a newly discovered meiotic and embryonic competence factor safeguarding genome integrity at the onset of life.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Histone methylation; Meiosis; Mitosis; Pre-implantation development; Transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 27317807     DOI: 10.1242/dev.132746

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  30 in total

Review 1.  A drive in SUVs: From development to disease.

Authors:  Vinay Kumar Rao; Ananya Pal; Reshma Taneja
Journal:  Epigenetics       Date:  2017-01-20       Impact factor: 4.528

Review 2.  Silencing of endogenous retroviruses by heterochromatin.

Authors:  Sophia Groh; Gunnar Schotta
Journal:  Cell Mol Life Sci       Date:  2017-02-03       Impact factor: 9.261

3.  Selfish DNA and Epigenetic Repression Revisited.

Authors:  Susan M Gasser
Journal:  Genetics       Date:  2016-11       Impact factor: 4.562

Review 4.  The molecular basis of the organization of repetitive DNA-containing constitutive heterochromatin in mammals.

Authors:  Gohei Nishibuchi; Jérôme Déjardin
Journal:  Chromosome Res       Date:  2017-01-11       Impact factor: 5.239

Review 5.  The control of gene expression and cell identity by H3K9 trimethylation.

Authors:  Maria Ninova; Katalin Fejes Tóth; Alexei A Aravin
Journal:  Development       Date:  2019-09-20       Impact factor: 6.868

6.  ATF7IP regulates SETDB1 nuclear localization and increases its ubiquitination.

Authors:  Takeshi Tsusaka; Chikako Shimura; Yoichi Shinkai
Journal:  EMBO Rep       Date:  2019-10-02       Impact factor: 8.807

7.  EHMT2 and SETDB1 protect the maternal pronucleus from 5mC oxidation.

Authors:  Tie-Bo Zeng; Li Han; Nicholas Pierce; Gerd P Pfeifer; Piroska E Szabó
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-14       Impact factor: 11.205

8.  Expression of the histone lysine methyltransferases SETD1B, SETDB1, SETD2, and CFP1 exhibits significant changes in the oocytes and granulosa cells of aged mouse ovaries.

Authors:  Yesim Bilmez; Gunel Talibova; Saffet Ozturk
Journal:  Histochem Cell Biol       Date:  2022-04-20       Impact factor: 4.304

9.  The Essential Function of SETDB1 in Homologous Chromosome Pairing and Synapsis during Meiosis.

Authors:  Ee-Chun Cheng; Chia-Ling Hsieh; Na Liu; Jianquan Wang; Mei Zhong; Taiping Chen; En Li; Haifan Lin
Journal:  Cell Rep       Date:  2021-01-05       Impact factor: 9.423

Review 10.  Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression.

Authors:  Nirmalya Saha; Andrew G Muntean
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-26       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.